SCHAUMBURG, Ill.--(BUSINESS WIRE)--APP Pharmaceuticals, Inc. (Nasdaq:APPX) today announced the launch of enhanced labeling for its line of Heparin Sodium Injection, USP. The labels and cap colors for APP’s heparin have incorporated clearly differentiating color combinations since the company began marketing the product in 1998. Also, the current product’s labels include bar codes at the individual unit-of-use. APP’s new labeling represents further enhancements to help differentiate Heparin Sodium from other heparin products, including Heparin Lock Flush Solution, USP. As part of the company’s long-standing commitment to patient care and in response to concerns regarding a higher risk of medication errors associated with heparin, the new labeling will further help healthcare professionals quickly identify the correct drug and ultimately administer the proper dose.
